Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Novack, Victor ^a,b   Pencina, Michael ^b   Zahger, Doron ^a   Fuchs, Lior ^a   Nevzorov, Roman ^a   Jotkowitz, Allan ^a   Porath, Avi ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE; POTASSIUM; SODIUM; UREA; URIC ACID;

ABNORMAL LABORATORY RESULT; ACUTE HEART FAILURE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ERYTHROCYTE COUNT; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HYPOALBUMINEMIA; HYPONATREMIA; ISRAEL; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; POTASSIUM BLOOD LEVEL; PREDICTION; SCORING SYSTEM; SODIUM BLOOD LEVEL; SURVIVAL TIME; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; VALIDATION STUDY; BLOOD; CALIBRATION; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIAGNOSTIC TEST; ECHOGRAPHY; HEART FAILURE; HOSPITALIZATION; MULTIVARIATE ANALYSIS; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK; TIME;

AGED; CALIBRATION; CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK; TIME FACTORS;

EID: 77957867160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012184     Document Type: Article

References (30)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, et al. (2007) Heart Disease and Stroke Statistics-2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115: e69-e171.
2. Mitchell JE (2007) Emerging role of anemia in heart failure. Am J Cardiol 99: 15D-20D.
3. Cooper HA, Exner DV, Waclawiw MA, Domanski MJ (1999) White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 84: 252-257.
4. De Denus S, White M, Tardif JC, Bourassa MG, Racine N, et al. (2006) Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunction. J Card Fail 12: 353-359.
5. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, et al. (2006) Renal impairment and outcomes in heart failure: systematic review and metaanalysis. J Am Coll Cardiol 47: 1987-1996.
6. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, et al. (2006) Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Arch Intern Med 166: 1134-1142.
7. Adrogue HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342: 1581-1589.
8. Oren RM (2005) Hyponatremia in congestive heart failure. Am J Cardiol 95: 2B-7B.
9. Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Pina IL, et al. (2005) Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 111: 2454-2460.
10. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, et al. (2004) Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543-551.
11. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, et al. (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107: 1991-1997.
12. Pascual-Figal DA, Hurtado-Martinez JA, Redondo B, Antolinos MJ, Ruiperez JA, et al. (2007) Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 9: 518-524.
13. Anker SD, Sharma R (2002) The syndrome of cardiac cachexia. Int J Cardiol 85: 51-66.
14. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155: 883-889.
15. Sewdarsen M, Vythilingum S, Jialal I, Becker PJ (1989) Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 71: 461-466.
16. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, et al. (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164: 982-988.
17. Battaglia M, Pewsner D, Juni P, Egger M, Bucher HC, et al. (2006) Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch Intern Med 166: 1073-1080.
18. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, et al. (2007) Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 13: 42-49.
19. Maisel A. Biomarkers in the Assessment of Congestive Heart Failure Mid-Regional pro-Adrenomedullin (MR-proADM) vs BNP &NT-proBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial; 2008; New-Orleans, LA.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
21. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, et al. (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355: 2631-2639.
22. Hastie TJ, Tibshirani RJ (1990) Generalized Additive Models. New York: Chapman and Hall.
23. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
24. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, et al. (2003) Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290: 2581-2587.
25. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, et al. (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95: 2660-2667.
26. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, et al. (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113: 1424-1433.
27. Fonarow GC, Adams KF, Jr., Abraham WT, Yancy CW, Boscardin WJ (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293: 572-580.
28. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, et al. (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016.
29. Metra M, Nodari S, Parrinello G, Specchia C, Brentana L, et al. (2007) The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail.
30. Jotkowitz AB, Porath A, Shotan A, Mittelman M, Grossman E, et al. (2006) Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey. Isr Med Assoc J 8: 875-879.